Qinecsa provides tailored signal detection and risk management services for clinical and commercial products, including associated benefit-risk management activities. With diverse therapeutic expertise and industry-leading
The Vigilance Workbench signal detection platform spans the full spectrum of the signal management process to ensure all potential signals are tracked with clear prioritization.
Qinecsa provides complete and compliant safety and pharmacovigilance frameworks to support clinical and commercial products.
Qinecsa provides industry-leading medical and safety call center services led by our team of highly experienced specialists. Our teams provide support covering a diverse range
Qinecsa’s team of experts is looking forward to connecting with you at the Virtue Insights 34th Pharmacovigilance UK & EU 2024 to explore the latest
Qinecsa’s team of experts is looking forward to connecting with you at the DIA Global Pharmacovigilance and Risk Management Strategies Conference 2024. DIA’s Global Pharmacovigilance
Announcement – 14th December 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of John Freeman JD, M.Sc., B.Sc. as Non-executive
Announcement – Qinecsa Solutions Launches Next-Generation Literature Management Solution in Collaboration with AAICO, Revolutionizing Pharmacovigilance with AI London, December 13, 2023 – Qinecsa Solutions,
Qinecsa is on a mission to drive positive change in the pharmacovigilance industry. As we enter a new year with exciting plans to continue advancing
6 November 2023, London – Qinecsa Solutions, specialists in technology-led end-to-end pharmacovigilance solutions, today announced the appointment of Arthur Shih as General Counsel. With over
